Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter’s syndrome

類似資料

• The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease
  著者:: Appleby, Niamh, 等
  出版事項: (2019)
• Phase II Study of Bendamustine and Ofatumumab in Elderly Patients with Newly Diagnosed Diffuse Large B‐Cell Lymphoma Who Are Poor Candidates for R‐CHOP Chemotherapy
  著者:: Flinn, Ian W., 等
  出版事項: (2019)
• Renal outcome in patients with newly diagnosed multiple myeloma: results from the UK NCRI Myeloma XI trial
  著者:: Rana, Ritika, 等
  出版事項: (2020)
• Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed Glioblastoma
  著者:: Skardelly, Marco, 等
  出版事項: (2017)
• Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukemia: final results of the NCRI CLL210 trial
  著者:: Pettitt, Andrew R., 等
  出版事項: (2020)